Varicella Zoster Immune Globulin (VZIG)
VZIG is human immune serum globulin containing antibodies to varicella-zoster virus for post-exposure prophylaxis in immunocompromised patients. It is classified under HTS 3002.12.0030 as human immune blood sera from donors with recent varicella infection or vaccination. Administered intramuscularly within 96 hours of exposure.
Import Duty Rates by Country of Origin
| Origin Country | MFN Rate | Ch.99 Surcharges | Total Effective Rate |
|---|---|---|---|
| 🇨🇳China | Free | — | Free |
| 🇲🇽Mexico | Free | — | Free |
| 🇨🇦Canada | Free | — | Free |
| 🇩🇪Germany | Free | — | Free |
| 🇯🇵Japan | Free | — | Free |
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If standard IVIG for general use
Non-specific polyvalent immunoglobulins lack VZV-specific immune serum status.
If in clinical trial placebo kits
Blinded trial materials containing sera classify under Chapter 3006.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Provide evidence of donor VZV seropositivity; FDA lot-by-lot review mandatory
• Ship in validated frozen containers; monitor for freeze-thaw cycles
• Avoid bulk import without U.S. agent registration per plasma rules
Related Products under HTS 3002.12.00.30
RhoGAM Human Immune Serum
RhoGAM is a human immune globulin derived from plasma containing antibodies against the Rho(D) antigen, used to prevent Rh hemolytic disease in newborns. It qualifies under HTS 3002.12.0030 as human immune blood sera prepared for prophylactic use in preventing alloimmunization in Rh-negative mothers. This sterile, injectable product is biotechnologically processed from human plasma.
HyperRAB Human Rabies Immune Globulin
HyperRAB is a purified human immune serum globulin providing passive rabies virus antibodies for post-exposure prophylaxis. Classified under HTS 3002.12.0030 as human immune blood sera due to its origin from plasma of rabies-vaccinated human donors. It is administered intramuscularly alongside vaccine for immediate protection.
Cytomegalovirus Immune Globulin Intravenous (CMV IGIV)
CMV IGIV is a human immune serum containing high-titer antibodies against cytomegalovirus, used prophylactically in transplant patients. It falls under HTS 3002.12.0030 as human immune blood sera fractionated from pooled plasma of immunized donors. The product is formulated for intravenous administration to prevent CMV disease.
Vaccinia Immune Globulin (VIG)
VIG is human immune serum globulin rich in antibodies against vaccinia virus, used to manage complications from smallpox vaccination. Under HTS 3002.12.0030 as human immune blood sera from donors vaccinated with vaccinia. It provides passive immunity via intravenous or intramuscular injection.
Hepatitis B Immune Globulin (HBIG)
HBIG is a human immune serum providing high-titer anti-HBs antibodies for post-exposure prophylaxis against hepatitis B virus. Classified in HTS 3002.12.0030 as human immune blood sera from HBV-vaccinated or recovered donors. It is essential for preventing mother-to-child transmission and needle-stick exposures.